Insights on AI, practice management, and clinical optometry.
Use a structured NBEO Part III skills guide to organize clinical procedures, station flow, anterior segment skills, posterior segment skills, and exam-day readiness.
Prepare for NBEO Part III with realistic patient encounters, timed case flow, patient chat, ancillary testing, diagnosis, management planning, and targeted feedback.
Learn how to use OptoConnections for daily board-style practice, clinical review, and fast skill-building across optics, pharmacology, and patient care topics.
Explore the most useful OptoConnections resources for rapid exam review, chairside confidence, and structured practice before clinic and practical exams.
Daily puzzle repetition builds durable recall for exams and clinic. See how OptoConnections uses short, focused challenges to improve retention over time.
A complete overview of OptoConnections features, from news and learning modules to exam prep tools that support optometry students and clinicians.
Artificial intelligence is transforming optometry with unprecedented accuracy in detecting diabetic retinopathy, glaucoma, and macular degeneration. FDA-approved AI systems now achieve 98.5% sensitivity in diabetic retinopathy screening and can detect glaucoma changes 18 months earlier than traditional methods. Discover how AI-powered diagnostic tools are enhancing patient outcomes, increasing practice efficiency by 30-40%, and delivering 340% ROI over three years.
Learn proven strategies to grow your optometry practice through digital marketing, patient retention programs, and strategic partnerships. Practices implementing these approaches see 25-40% revenue growth, with medical optometry services increasing revenue per patient by 172%. Discover how local SEO optimization drives 3x more appointments, automated recall systems achieve 85% show rates, and strategic technology investments deliver 300%+ ROI.
New research reveals groundbreaking myopia control treatments showing up to 60-70% reduction in progression. Orthokeratology and low-dose atropine achieve 50-60% efficacy, while combination therapy can reach 70% reduction. Explore the latest evidence on FDA-approved treatments including MiSight contact lenses, spectacle lens designs, and clinical protocols for pediatric myopia management.
Weekly ideas for staying sharp in class, boards, and clinic. No spam.